SRTS240517P7500
- 2.20
- 0.000.00%
Sensus Healthcare Newsroom
Sensus Healthcare Is Maintained at Buy by HC Wainwright & Co.
Sensus Healthcare Is Maintained at Buy by HC Wainwright & Co.
HC Wainwright & Co. Maintains Buy on Sensus Healthcare, Raises Price Target to $10
HC Wainwright & Co. analyst Yi Chen maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and raises the price target from $8 to $10.
Is Sensus Healthcare, Inc.'s (NASDAQ:SRTS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
NVAX, GRPN and MVIS Among Mid-day Movers
Sensus Healthcare | 10-Q: Quarterly report
Sensus Healthcare Is Maintained at Buy by Maxim Group
Sensus Healthcare Is Maintained at Buy by Maxim Group
Maxim Group: Maintains Sensus Healthcare (SRTS.US) rating, adjusted from buy to buy rating, and adjusted target price from $7.00 to $10.00.
Maxim Group: Maintains Sensus Healthcare (SRTS.US) rating, adjusted from buy to buy rating, and adjusted target price from $7.00 to $10.00.
Maxim Group Maintains Buy on Sensus Healthcare, Raises Price Target to $10
Maxim Group analyst Anthony Vendetti maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and raises the price target from $7 to $10.
Sensus Healthcare Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 115.99% Maxim Group $7 → $10 Maintains Buy 11/13/2023 72.79% HC Wainwright & Co. → $8 Reiterate
Novavax, Macrogenics, Biofrontera Among Healthcare Movers
Sensus Healthcare Shares Are Trading Higher After Following the Company's Better-than-expected Q1 Financial Results.
Sensus Healthcare Shares Are Trading Higher After Following the Company's Better-than-expected Q1 Financial Results.
Why Natera Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Shares of Natera, Inc. (NASDAQ:NTRA) rose sharply in today's pre-market trading following strong first-quarter earnings.
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersAethlon Medical (NASDAQ:AEMD) stock moved upwards by 129.0% to $2.7 during Friday's pre-market session. The company's market cap stands at $7.1 million. Novavax (NASDAQ:NVAX) shares rose 119.23
Sensus Healthcare Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results.
Sensus Healthcare Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results.
Sensus Healthcare Q1 2024 GAAP EPS $0.14 Beats $(0.06) Estimate, Sales $10.663M Beat $4.120M Estimate
Sensus Healthcare (NASDAQ:SRTS) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $(0.06) by 333.33 percent.
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersSensus Healthcare (NASDAQ:SRTS) shares increased by 33.3% to $5.08 during Thursday's after-market session. The market value of their outstanding shares is at $83.2 million. As per the news, the
Earnings Flash (SRTS) SENSUS HEALTHCARE Reports Q1 Revenue $10.7M
04:15 PM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (SRTS) SENSUS HEALTHCARE Reports Q1 Revenue $10.7M
Sensus Healthcare 1Q EPS 14c >SRTS
Sensus Healthcare 1Q EPS 14c >SRTS
Largest Veterinary Emergency Hospital In Tel Aviv Acquires Sensus Healthcare's SRT-100(TM) To Provide Gentler Radiotherapy To Treat Tumors In Dogs And Cats SRTS
Largest Veterinary Emergency Hospital In Tel Aviv Acquires Sensus Healthcare's SRT-100(TM) To Provide Gentler Radiotherapy To Treat Tumors In Dogs And Cats SRTS
Sensus Healthcare Issues Reminder That Its First Quarter 2024 Financial Results and Business Update Conference Call Will Be Held on Thursday, May 9, 2024
BOCA RATON, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological